Annual Drug Patent Expirations for LONHALA+MAGNAIR+KIT
Lonhala Magnair Kit is a drug marketed by Sumitomo Pharma Am and is included in one NDA. There are twelve patents protecting this drug.
Drug patent litigation for LONHALA MAGNAIR KIT.
This drug has seventy-six patent family members in fifteen countries.
The generic ingredient in LONHALA MAGNAIR KIT is glycopyrrolate. Additional details are available on the glycopyrrolate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
